Financials

  • Market Capitalization 403.53 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
3.68
市销率
35.88

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3030
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
3.72 USD0.00%-1.59%+18.85%+13.76%408.36 M USD
3031
CMPX
Compass Therapeutics, Inc. - Common Stock
2.32 USD-2.93%-8.30%+19.59%-32.75%417.80 M USD
3051
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.91 USD+2.36%-5.10%+2.09%+6.83%406.18 M USD
3085
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.46 USD+0.98%-5.81%+5.98%+54.71%392.03 M USD

新闻